AGENDA
LEARNING OBJECTIVES
Upon completion of Session 1, participants will have:
-
- Increased knowledge regarding the recent clinical data on emerging and novel pharmacologic therapies for mood disorders
- Greater competence related to the clinical management of patients with MDD experiencing comorbid conditions
- Greater competence in identifying depressive episodes related to MDD versus bipolar depression
- Greater confidence in their ability to incorporate interprofessional strategies into MDD and bipolar spectrum care
LEARNING OBJECTIVES
Upon completion of Session 2, participants will have:
-
- Greater competence related to the selection of treatments for the clinical management of insomnia
- Increased knowledge regarding the recognition of signs and symptoms associated with narcolepsy
- Increased knowledge regarding the relationship between sleep disorders and psychiatric disorders
LEARNING OBJECTIVES
Upon completion of Session 3, participants will have:
-
- Greater competence related to the appropriate selection of treatment for patients with psychosis related to Parkinson’s disease
- Increased knowledge regarding the symptoms of psychosis in patients with Alzheimer’s disease and other forms of dementia
- Increased knowledge on treatment impact on cognitive function and cognitive dysfunction related to psychiatric conditions
LEARNING OBJECTIVES
Upon completion of Session 4, participants will have:
-
- Increased knowledge regarding the impact of the COVID-19 pandemic on the prevalence of and risks for behavioral health disorders in pediatric patients
- Increased knowledge regarding the recent clinical data on emerging and novel interventions for ADHD
- Greater competence related to implementing best practices in pharmacologic and non-pharmacologic management of OCD in adolescent patients
- Increased knowledge regarding the recent clinical data on emerging and novel tools for ASD screening and diagnosis
- Increased knowledge regarding the up-to-date evidence on clinical interventions for pediatric patients with ASD
- Greater confidence in their ability to incorporate interprofessional strategies into adolescent psychiatric care
LEARNING OBJECTIVES
Upon completion of Session 5, participants will have:
-
- Increased knowledge regarding the recent clinical data on emerging and novel treatments for patients with schizophrenia
- Greater competence related to integrating knowledge of metabolic comorbidities into treatment decision making for patients with schizophrenia
LEARNING OBJECTIVES
Upon completion of Session 7, participants will have:
-
- Increased knowledge regarding the advancements in treatment for postpartum depression
- Increased knowledge regarding the impact of social and racial determinants on perinatal mental health
- Increased knowledge regarding the available data on perinatal mental health outcomes during the COVID-19 pandemic
- Greater confidence in their ability to incorporate interprofessional strategies into psychiatric care
One Mind: The Leading Brain Health Nonprofit Organization committed to healing the lives of people impacted by brain illness and injury Medscape is pleased to donate $10 on your behalf when you register for this event. The donation will go to One Mind which exemplifies research and advocacy in the Psychiatric community.
center
cover
fixed
vertical